Home » Newsletters » BioWorld Science

BioWorld Science

April 2, 1997

View Archived Issues

Lilly continues to develop compounds for postmenopausal syndrome

Endothelin antagonists from SmithKline Beecham

Wyeth-Ayerst describes antiinflammatory agents

MS&D prepares antimigraine pyrrolo-pyridine derivatives

Centocor describes peptide inhibitors of selectin binding

Novel antitumor agents from Universidad Complutense

Positive preliminary clinical results for Atragen in leukemia and Kaposi's sarcoma

Selective CB2 receptor agonists prepared by Merck Frosst

Major gene associated with glioblastoma multiforme discovered

New device for carpal tunnel syndrome

Hokuriku discloses agents for urinary incontinence

Vasopressin antagonists from JT

IDE sought for new technique for glaucoma surgery

New HPV DNA test introduced in Europe

Procept's PRO-2000 covered by U.S. patent

Cationized AVP fragment for learning and memory disorders from Yakult

Guilford's neuroimmunophilin ligands covered by U.S. patent

FDA tentatively approves generic acyclovir

Stavudine delays HIV progression in zidovudine-experienced patients

VIMRx licenses factor IXa inhibitor from Columbia University

Transdermal nicotine associated with clinical improvement in ulcerative colitis

IntraBiotics/Synt:em to develop protegrin analogues

Abgenix acquires rights to antibody for transplant rejection

First Estrophasic OC introduced in the U.S.

New low-dose OC cleared by FDA

Dusa reports data on Levulan as CIN therapy

New epilepsy option approved in the U.S.

Preliminary data reported from Alkermes' RMP-7/carboplatin phase II trial

Pharmadigm's PB-OO5 enters phase II as burn treatment

Amylin acquires rights to cardiovascular agents from Hoechst Marion Roussel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...